{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:36:49Z","timestamp":1791203809771,"version":"4.2.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Based on preclinical data, cell-based therapy with bone marrow\u2013derived mesenchymal stem (stromal) cells (MSCs) is a potentially attractive new therapeutic option for treating patients with the acute respiratory distress syndrome. Small and large animal models of acute lung injury from endotoxin, live bacteria, and sepsis have shown that MSCs can decrease lung injury and increase survival. The mechanisms for benefit are mediated in part by paracrine release of several antiinflammatory cytokines, keratinocyte growth factor, angiopoietin-1, as well as the release of antimicrobial peptides. There is also evidence that MSCs can transfer mitochondria and restore normal bioenergetics to injured alveolar epithelium. Some of the beneficial effects are mediated by microvesicles. A phase 1 safety and dose-escalation trial was completed and a randomized, double-blind clinical trial is currently underway.<\/jats:p>","DOI":"10.1513\/annalsats.201406-254mg","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T09:20:34Z","timestamp":1427966434000},"page":"S54-S57","source":"Crossref","is-referenced-by-count":43,"title":["Therapeutic Potential of Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome"],"prefix":"10.1093","volume":"12","author":[{"given":"Michael A.","family":"Matthay","sequence":"first","affiliation":[{"name":"Department of Medicine, Department of Anesthesia, and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"key":"2026012303381348200_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.10-0518","article-title":"Therapeutic potential of mesenchymal stem cells for severe acute lung injury","volume":"138","author":"Matthay","year":"2010","journal-title":"Chest"},{"key":"2026012303381348200_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/stem.643","article-title":"Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors","volume":"29","author":"Lee","year":"2011","journal-title":"Stem Cells"},{"key":"2026012303381348200_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"2026012303381348200_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/thoraxjnl-2011-201176","article-title":"Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia","volume":"67","author":"Gupta","year":"2012","journal-title":"Thorax"},{"key":"2026012303381348200_bib5","doi-asserted-by":"crossref","first-page":"L1003","DOI":"10.1152\/ajplung.00180.2011","article-title":"Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes","volume":"302","author":"Krasnodembskaya","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303381348200_bib6","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","article-title":"Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1","volume":"4","author":"Mei","year":"2007","journal-title":"PLoS Med"},{"key":"2026012303381348200_bib7","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"T\u00f6gel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026012303381348200_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2026012303381348200_bib9","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1073\/pnas.0704421104","article-title":"Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury","volume":"104","author":"Ortiz","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303381348200_bib10","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J Immunol"},{"key":"2026012303381348200_bib11","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"2026012303381348200_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303381348200_bib13","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","article-title":"Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303381348200_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303381348200_bib15","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"306","author":"McAuley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303381348200_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/thoraxjnl-2013-204980","article-title":"Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia","volume":"69","author":"Asmussen","year":"2014","journal-title":"Thorax"},{"key":"2026012303381348200_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"key":"2026012303381348200_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13613-014-0022-z","article-title":"McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, et al. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1\/2 trial of human mesenchymal stem\/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome","volume":"4","author":"Liu","year":"2014","journal-title":"Ann Intensive Care"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/Supplement_1\/S54\/66445770\/annalsats_12_supplement_1_s54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/Supplement_1\/S54\/66445770\/annalsats_12_supplement_1_s54.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:38:24Z","timestamp":1769157504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/12\/Supplement_1\/S54\/8429223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":18,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2015,3,1]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201406-254mg","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,3]]},"published":{"date-parts":[[2015,3,1]]}}}